Testosterone and cardiovascular risk in patients with erectile dysfunction
- PMID: 22082753
- DOI: 10.3275/8063
Testosterone and cardiovascular risk in patients with erectile dysfunction
Abstract
Background: The relationship between cardiovascular (CV) diseases (CVD) and testosterone (T) levels in men has not been completely clarified.
Aim: To evaluate the association between T levels and CV risk in subjects with erectile dysfunction (ED) and to verify whether their body mass index might (BMI) represents a possible confounder in T-related CV stratification.
Material and methods: A consecutive series of 2269 male patients attending the Outpatient Clinic for ED was studied. The assessment of CV risk was evaluated using the engine derived from the Progetto Cuore study.
Results: After adjustment and for BMI and associated morbidities, SHBG-bound and -unbound T levels decreased as a function of CV risk assessed thorough Progetto Cuore risk engine. In addition, a higher prevalence of hypogonadism related symptoms and signs was associated with a higher CV risk. Among factors included in the Progetto Cuore risk engine age, total and HDL cholesterol and diabetes were all significantly associated with CV risk-dependent modification of total and calculated free-T levels. When the relationship between SHBG bound and unbound T and CV risk was evaluated as a function of obesity (BMI>30 kg/m(2)), all the aforementioned associations were confirmed only in non obese patients.
Conclusions: Hypogonadism could be associated either with an increased or reduced CV risk, depending on the characteristics of subjects. Low T observed in obese patients might represent the result of higher CV risk rather than a direct pathogenetic mechanism.
Similar articles
-
Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction.J Sex Med. 2011 Jul;8(7):2098-105. doi: 10.1111/j.1743-6109.2011.02292.x. Epub 2011 May 11. J Sex Med. 2011. PMID: 21561538
-
The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction.J Sex Med. 2010 Apr;7(4 Pt 1):1547-56. doi: 10.1111/j.1743-6109.2009.01698.x. Epub 2010 Feb 5. J Sex Med. 2010. PMID: 20141585
-
The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction.J Sex Med. 2013 Apr;10(4):1114-23. doi: 10.1111/jsm.12066. Epub 2013 Jan 24. J Sex Med. 2013. PMID: 23347470
-
Obesity, low testosterone levels and erectile dysfunction.Int J Impot Res. 2009 Mar-Apr;21(2):89-98. doi: 10.1038/ijir.2008.42. Epub 2008 Oct 9. Int J Impot Res. 2009. PMID: 18843273 Review.
-
The Graham Jackson Memorial Lecture ISSM 2016-"The Man Who Knew Too Much": Time to Recognize Erectile Dysfunction and Low Testosterone as Independent Risk Factors for Cardiovascular Disease.Sex Med Rev. 2017 Jul;5(3):256-265. doi: 10.1016/j.sxmr.2017.02.002. Epub 2017 Mar 21. Sex Med Rev. 2017. PMID: 28341581 Review.
Cited by
-
A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.Can Urol Assoc J. 2014 May;8(5-6):E356-7. doi: 10.5489/cuaj.1962. Can Urol Assoc J. 2014. PMID: 24940464 Free PMC article. No abstract available.
-
Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology.J Endocrinol Invest. 2015 Jan;38(1):103-12. doi: 10.1007/s40618-014-0155-9. Epub 2014 Nov 11. J Endocrinol Invest. 2015. PMID: 25384570 Free PMC article.
-
Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.J Sex Med. 2014 Feb;11(2):553-62. doi: 10.1111/jsm.12369. Epub 2013 Nov 6. J Sex Med. 2014. PMID: 24344902 Free PMC article.
-
Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma.Acta Neurochir (Wien). 2024 Jul 31;166(1):314. doi: 10.1007/s00701-024-06213-9. Acta Neurochir (Wien). 2024. PMID: 39085672 Free PMC article.
-
Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry.J Endocrinol Invest. 2016 Jun;39(6):695-708. doi: 10.1007/s40618-016-0461-5. Epub 2016 Apr 1. J Endocrinol Invest. 2016. PMID: 27037688
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous